Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $125
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $125
Canaccord Genuity維持對merit medical systems的買入評級，將目標股價上調至125美元。
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the price target from $102 to $125.
Canaccord Genuity分析師Jon Young維持Merit Medical Systems（納斯達克：MMSI）的買入評級，並將目標價從102美元上調至125美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。